RETRACTION: YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis (Retraction of Vol 129, art no 10.1016/J.BIOPHA.2020.110339, 2020)

被引：0
|
作者：
You, Qi [1 ]
Yao, Yuan [2 ]
Wu, Jinyu [1 ]
Cheng, Congcong [1 ]
Li, Yunxiu [1 ]
Yuan, Haitao [1 ]
机构：
[1] Harbin Med Univ, Dept Gynecol & Obstet, Affiliated Hosp 1, Harbin 150001, Heilongjiang, Peoples R China
[2] Harbin Med Univ, Dept Infect Monitor, Affiliated Hosp 1, Harbin 150001, Heilongjiang, Peoples R China
来源：
BIOMEDICINE & PHARMACOTHERAPY | 2021年 / 141卷
关键词：
D O I：
10.1016/j.biopha.2021.111986
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：1
相关论文
共 21 条
  • [1] RETRACTED: YY1-induced lncRNA DSCR8 promotes the progression of ovarian cancer via miR-3192-5p/YY1 axis (Retracted article. See vol. 141, 2021)
    You, Qi
    Yao, Yuan
    Wu, Jinyu
    Cheng, Congcong
    Li, Yunxiu
    Yuan, Haitao
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 129
  • [2] YY1-induced lncRNA00511 promotes melanoma progression via the miR-150-5p/ADAM19 axis
    Chen, Ya-Ni
    Fu, Xin-Rui
    Guo, Hua
    Fu, Xin-Yao
    Shi, Ke-Song
    Gao, Tian
    Yu, Hai-Quan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (02):
  • [3] RETRACTION: Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ ROCK2 axis (Vol 125, 109882, 2020) (Retraction of Vol 125, 10.1016/J.BIOPHA.2020.109882, 2020)
    Liu, Xiaoxia
    Li, Yiyang
    Wen, Jihong
    Qi, Tingting
    Wang, Yanli
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [4] RETRACTION: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis (Retraction of Vol 19, art no 85, 2020)
    Liang, Yiran
    Song, Xiaojin
    Li, Yaming
    Chen, Bing
    Zhao, Wenjing
    Wang, Lijuan
    Zhang, Hanwen
    Liu, Ying
    Han, Dianwen
    Zhang, Ning
    Ma, Tingting
    Wang, Yajie
    Ye, Fangzhou
    Luo, Dan
    Li, Xiaoyan
    Yang, Qifeng
    MOLECULAR CANCER, 2022, 21 (01)
  • [5] RETRACTION: The lncRNA XIST promotes colorectal cancer cell growth through regulating the miR-497-5p/FOXK1 axis (Retraction of Vol 20, art no 553, 2020)
    Wang, Nan
    He, Jia-Xing
    Jia, Guo-Zhan
    Wang, Ke
    Zhou, Shuai
    Wu, Tao
    He, Xian-Li
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [6] RETRACTION: LncRNA MALAT1 Promotes Survival of Epithelial Ovarian Cancer Cells by Downregulating miR-145-5p (Retraction of Vol 12, Pg 11359, 2020)
    Wang, K.
    Zhao, Y.
    Wang, Y. M.
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7251 - 7251
  • [7] RETRACTION: LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APE1 Axis (Retraction of Vol 13, Pg 10607, 2020)
    Lu, M.
    Liu, D.
    Li, Y.
    ONCOTARGETS AND THERAPY, 2022, 15 : 701 - 701
  • [8] RETRACTION: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retraction of Vol 12, Pg 9999, 2020)
    Wang, Y.
    Wang, X.
    Han, L.
    Hu, D.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3457 - 3457
  • [9] RETRACTION: LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis (Retraction of Vol 16, Pg 733, 2013)
    Bi, H.
    Shang, Z.
    Jia, C.
    ONCOTARGETS AND THERAPY, 2022, 15 : 681 - 681
  • [10] RETRACTION: LncRNA KCNQ1OT1 inhibits the radiosensitivity and promotes the tumorigenesis of hepatocellular carcinoma via the miR-146a-5p/ACER3 axis (Retraction of Vol 2519, Pg 19, 2020)
    Gontijo, Bruna A.
    Fonseca, Sergio T.
    Araujo, Priscila A.
    Magalhaes, Fabricio A.
    Trede, Renato G.
    Faria, Henrique P.
    Resende, Renan A.
    Souza, Thales R.
    CELL CYCLE, 2023, 22 (06) : 738 - 738
123